Featured News
Careers
Awards & Accreditations
University of Nevada, Reno
Renown Health Foundation
Media Resources
Renown Health's public relations team supports media partners in finding experts on diverse health care topics. In addition, we provide information and answer all questions regarding Renown. We look forward to working with you.
-
Media On Campus
For patient confidentiality purposes, Renown Health policies require media to be escorted by the public relations staff at all times.
PR staff will gladly make parking arrangements, notify the appropriate hospital staff and help you find your destination.
Stand Ups/Live Broadcasts
Media may conduct stand ups and live broadcasts on our campuses. In the interest of patient confidentiality and traffic flow, a staff member will help you find the best location for your story.
We ask you to respect our obligation to protect our patients' well-being and legal right to privacy.
-
Patient Condition Inquiry
We follow regulations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) for all patients, including patients of public interest. HIPAA regulations specify which information may and may not be released without authorization from a patient.
Patient privacy regulations allow us to only share patient condition information about patients that appear in our directory.
Media inquiries require correct spelling of the patient's first and last name.
Definitions of "Condition" used by Renown Health
When describing a patient's condition, we can only release the following patient statuses:
Good - Vital signs such as pulse, temperature and blood pressure are stable and within normal limits. Patient is conscious, comfortable and there are no complications.
Fair - Vital signs are stable and within normal limits. Patient is conscious and alert although may be uncomfortable or in pain and may have minor complications.
Serious - Vital signs may be unstable or outside normal limits. The patient is acutely ill or injured and may have major complications.
Critical - Vital signs are unstable or outside normal limits. There are major complications.
Note: "Stable" is not a condition.
Press Releases
-
Study From UNR Med and Renown in JAMA Network Open Highlights Gaps in Genetic Screening for Hereditary Breast and Ovarian Cancer
Data demonstrates that a proactive approach to family history assessment and genetic screening will increase early detection of inherited risk. A new original investigation article published in JAMA Network Open, “Screening Familial Risk for Hereditary Breast and Ovarian Cancer,” by authors from University of Nevada, Reno School of Medicine, Renown Health and Helix for the Healthy Nevada Project® emphasizes the critical need to increase genetic screening in identifying individuals at increased risk of breast and ovarian cancer due to family history. This landmark study calls for enhanced awareness, the adoption of genetic screening practices, and, importantly, the direct screening of family history by individuals using a simple tool such as the FHS-7 questionnaire. Breast and ovarian cancers remain leading causes of cancer-related deaths, with genetic factors playing a key role in up to 10% of cases. The study authors advocate for wider adoption of screening protocols, simple family risk questionnaires and education about the benefits of genetic testing, not only for patients but also their family members who may share similar genetic risks. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 36 women will die from breast cancer. Since 1990, breast cancer death rates have declined progressively due to advancements in screening, treatment and detection. Here in Washoe County, Nev., the age-adjusted mortality rate for 2020 (last update) is 21 deaths/100,000 females due to breast cancer, which is higher and worse than the national U.S. value of 19.6. Nevada ranks near the bottom in breast and cervical cancer deaths in women according to a recent Commonwealth Fund report. Across the U.S., approximately 1.1 percent of women will be diagnosed with ovarian cancer at some point during their lifetime. The research underscores that individuals with a family history of breast and ovarian cancer have a higher likelihood of carrying genetic mutations in genes such as BRCA1 and BRCA2, which significantly elevate their cancer risk. However, many at-risk individuals remain unaware of their genetic predispositions due to limited screening practices. Evidence suggests that “up to 80% of patients with a pathogenic or likely pathogenic (P/LP) variant in the BRCA1 and BRCA2 genes are unaware of their condition and subsequent risk for hereditary breast and ovarian cancer. Rare or less penetrant P/LP variants in genes such as PALB2, CHEK2 and ATM are even less likely to be detected. This is concerning because the lifetime risk for breast cancer exceeds 50% for women with P/LP variants in BRCA1/2 and 20% for women in P/LP variants in PALB2, CHEK2 and ATM (compared with a baseline risk of 12%).” The study also found that men with family history are just as likely to have pathogenic variants in BRCA1 and BRCA2 as women. This is important because not only are men at increased risk of breast, prostate and other cancers, these risks are passed on to daughters, nieces and other members of the family through inheritance. Men are under-represented in the Healthy Nevada Project® and other similar population health studies. Daniel Kiser, MS, lead author of the study stated, "Our work shows that family history collected during routine medical care can be evaluated using simple criteria and used to identify patients with elevated risk for inherited cancers. Because there are a number of steps that can be taken to reduce risk, both for the patient and for their family members, following up with these patients has the potential to substantially reduce mortality and the incidence of cancer." “Prevention or early detection of disease is such an important part of healthcare,” says Bill Plauth, MD, MMM, CPE, Chief Medical Officer for Renown Health and Associate Dean for Clinical Affairs at the University of Nevada, Reno School of Medicine. “The Healthy Nevada Project® is leading the way in helping Renown Health physicians and clinicians assess family history risk of breast and ovarian cancer syndrome. This in turn, enables us to provide our at-risk patients the best available tools for prevention or to catch cancer at an earlier stage, which affords less aggressive treatment options with significantly improved survival.” The study found that routine genetic screening for individuals with a strong family history of these cancers could lead to more personalized and effective healthcare strategies, including preventative surgeries, increased surveillance, or early interventions. It also highlights the gap in awareness and access to genetic testing, particularly in underserved populations. “One of the lessons from our work is the importance of assessing family history early and often in the healthcare journey of patients,” says Joseph Grzymski, PhD, Chief Genomics Officer of Renown Health, the Principal Investigator of the Healthy Nevada Project, and a faculty member in the Department of Internal Medicine at the University of Nevada, Reno School of Medicine. “We recommend that everyone get screened for CDC Tier 1 conditions but particularly, when family history indicates risks, genetic screening is a powerful tool for risk stratification.” Key Recommendations from the Study Authors Include: Increased Engagement of Patients with Physicians: People with a family history should discuss their history with their primary care physician or health care provider and request a genetic screening. This proactive approach to prevention will save lives. Increased Access to Genetic Testing: The need for more accessible and affordable testing options, like the no-cost screening provided by the Healthy Nevada Project®, particularly for those with a family history of breast or ovarian cancer. Increased Pre-Screening and Genetic Counseling: Providing patients with the necessary counseling to understand the implications of genetic mutations and guide their healthcare decisions. Pre-screening patients with either a personal or family history of cancer with one of several simple family history tools, such as the FHS-7 Questionnaire to determine whether they should be referred for genetic services would also help increase early identification and reduce costs. As of January 2024, the Healthy Nevada Project® had notified 330 individuals with P/LP variants in BRCA1 or BRCA2 genes of their genetic risk, of a study population of more than 53,000 patients. The Healthy Nevada Project®, powered by Renown Health and University of Nevada, Reno School of Medicine, is one of the largest genomic studies in the United States. The genomic study is at no-cost for Nevadans and gives participants insight into different genetic traits, as well as results on their predisposition for three prevalent and serious health conditions known as the CDC Tier 1 conditions because of their significant potential to positively impact public health. Study authors include University of Nevada, Reno School of Medicine, (Daniel Kiser, MS; Gai Elhanhan, MD Iva Neveux, MS; William J. Metcalf, MS; Catherine McCarthy, MD; Leslie A. Greenberg, MD; Joseph J. Grzymski PhD); Helix, Inc. San Mateo, CA (Alexandre Bolze, PhD; Elizabeth T. Cirulli, PhD) and Renown Health, Reno (Savanna Grime, BA; Jamie M. Schnell Blitstein, APRN; William Plauth MD; Joseph J. Grzymski PhD. For more information on the study, please visit JAMA Network. For a media interview, please contact Dr. Joe Grzymski at news@renown.org. The Healthy Nevada Project®, led by Renown Institute for Health Innovation (Renown IHI) was launched in September 2016 as one of the first community-based population health studies in the United States. The study has already enrolled, consented and collected DNA from approximately 53,000 participants. Under the program, researchers and physicians are using genetics, environmental data and individual health information to empower providers with a targeted approach to personal health care and treatment, in turn improving the overall health and well-being of people in the local communities. The University of Nevada, Reno School of Medicine, Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents, and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national, and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.
-
Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results
Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively. “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.” The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.
-
Give the Gift of Health This Season with ELF Testing
Renown Health and the University of Nevada, Reno School of Medicine give the gift of early diagnosis and disease prevention this holiday season. With the season of giving upon us, give yourself the gift of health. The Renown Institute for Health Innovation (IHI) and the University of Nevada, Reno School of Medicine (UNR Med) are excited to offer a free Enhanced Liver Fibrosis (ELFTM) test to patients at risk for a common type of liver disease, e.g. metabolic and nonalcoholic steatohepatitis (M/NASH), and who enroll or are currently enrolled in the Healthy Nevada Project. The ELF Test is an FDA (Food and Drug Administration) approved non-invasive test to help identify people most at risk for liver scarring, e.g. cirrhosis, and allows doctors to intervene before irreversible damage occurs. If undetected and untreated, M/NASH can result in liver cirrhosis which could require liver transplantation or lead to death. This test is important as the symptoms of M/NASH can be silent or non-specific, making it difficult to diagnose. “There are currently more than 11,000 people across the U.S. on the national liver transplant waiting list, and with the heightened prevalence of NAFLD and M/NASH, this number is projected to keep rising; however, with research such as the ELF Test at our disposal, we are continuing to find ways to improve the health of those at risk for advanced liver disease,” said Bill Plauth, MD, Chief Medical Officer for Renown Health and Associate Dean of Clinical Affairs at UNR Med. “We encourage our community to participate in this early risk detection. Through this sophisticated, noninvasive, blood test, our physicians and Advanced Practice Providers can better evaluate liver fibrosis to help those affected and enable researchers to improve the prevention and treatment of nonalcoholic liver disease as a whole.” This liver health-focused sub-study of the Healthy Nevada Project seeks to enhance the understanding of both NAFLD and M/NASH and to help inform the development of treatment options for these conditions, as few currently exist. “Providing access to cutting-edge innovations such as the ELF Test is critical for both participants and the physicians and advanced practice providers that care for them.” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project and the Liver Disease Study and research professor at UNR Med. Those interested in determining their risk for M/NASH and its progression are encouraged to enroll in the Metabolic & Nonalcoholic Steatohepatitis study. Those who have consented and participated in the M/NASH research will be eligible and contacted with more information on how to receive the ELF Test. The Renown IHI is also happy to connect with physicians and Advanced Practice Providers interested in having their patients enroll in the Healthy Nevada Project and join the study. For members of the community who would like more information and learn how to enroll, please contact the Renown IHI at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact RenownIHI@renown.org or (775) 982-6914. In the U.S., the ELF Testing Service is available from Brio Clinical, Inc., a CLIA-certified laboratory offering specialized testing throughout the United States. Brio Clinical is regulated under CLIA as qualified to perform high complexity testing.
Read More About Give the Gift of Health This Season with ELF Testing
-
Renown Health Pulmonary Rehabilitation Program Certified by American Association of Cardiovascular and Pulmonary Rehabilitation
Renown Health is proud to announce the certification of its pulmonary rehabilitation program by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). This certification is recognition of Renown Health’s commitment to improving the quality of life of patients by enhancing standards of care. Pulmonary rehabilitation programs are designed to help people with pulmonary problems (e.g., chronic obstructive pulmonary disease [COPD], respiratory symptoms, long COVID-19) recover faster and live healthier. Both programs include exercise, education, counseling and support for patients and their families. According to the Center for Disease Control and Prevention, COPD impacts 16 million people across the United States, and 1 in 13 adults (7.5%) have “long COVID” symptoms, defined as symptoms lasting three or more months after first contracting the virus, and that they didn’t have prior to their COVID-19 infection. "We are thrilled to receive this certification from the American Association of Cardiovascular and Pulmonary Rehabilitation for our pulmonary rehabilitation program at Renown South Meadows Medical Center. This recognition underscores Renown Health's unwavering dedication to providing the highest standards of care and improving the lives of our patients, no matter what life throws at them,” said Sam Weller, MHPA CEO of Renown South Meadows Medical Center and Renown Rehabilitation Hospital. “Our commitment to excellence shines through in every aspect of our programs, and this certification reinforces our ongoing mission to make a positive impact on the health and well-being of the people of northern Nevada." To earn this accreditation, Renown Health’s pulmonary rehabilitation program participated in an application process that requires extensive documentation of the program’s practices. AACVPR Program Certification is the only peer-review accreditation process designed to review individual programs for adherence to standards and guidelines developed and published by AACVPR and other related professional societies. Each program’s application is reviewed by the AACVPR Program Certification Committee, and certification is awarded by the AACVPR Board of Directors. "At Renown Health, our pulmonary rehabilitation program is designed with our patients in mind. Our focus includes physical exercise, extending to education, counseling and support for both patients and their families,” said John Lynn, Manager of Respiratory Services at Renown Health. “This AACVPR certification is a testament to our team's hard work and dedication in ensuring that individuals with pulmonary conditions receive the best possible care to enhance their quality of life." In 2018, AACVPR moved to an outcomes-based process with performance measurements that represent more meaningful outcomes. Therefore, AACVPR-certified programs are leaders in the cardiovascular and pulmonary rehabilitation field because they offer the most advanced practices available and have proven track records of high-quality patient care. AACVPR Program Certification is valid for three years. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About AACVPR Founded in 1985, the American Association of Cardiovascular and Pulmonary Rehabilitation is a multidisciplinary organization dedicated to the mission of reducing morbidity, mortality and disability from cardiovascular and pulmonary disease through education, prevention, rehabilitation, research and disease management. Central to the core mission is improvement in quality of life for patients and their families.
-
Elevated Levels of Arsenic and Other Metals Found In Nevada Private Wells
Study shows that many household wells need better drinking water treatment and monitoring Outside of Nevada’s bustling cities, private wells are the primary source of drinking water, serving 182,000 people. Yet some of the tested private wells in Nevada are contaminated with levels of heavy metals that exceed federal, state or health-based guidelines, a new study published in Science of The Total Environment shows. Consuming water contaminated by metals such as arsenic can cause adverse health effects. Scientists from DRI and the University of Hawaii Cancer Center recruited households with private wells through the Healthy Nevada Project. Households were sent free water testing kits, and participants were notified of their water quality results and recommended actions they could take. More than 170 households participated in the research, with the majority from Northern Nevada around Reno, Carson City and Fallon. “The goals of the Healthy Nevada project are to understand how genetics, environment, social factors, and healthcare interact. We directly engaged our participants to better understand environmental contaminants that may cause adverse health outcomes,” said co-author Joseph Grzymski, PhD, research professor at DRI, principal investigator of the Healthy Nevada Project®, and chief scientific officer for Renown Health. Nearly one-quarter (22%) of the private wells sampled had arsenic that exceeded safe levels determined by the Environmental Protection Agency (EPA) — with levels 80 times higher than the limit in some cases. Elevated levels of uranium, lead, cadmium, and iron were also found. “We know from previous research that Nevada’s arid climate and geologic landscape produce these heavy metals in our groundwater,” says Monica Arienzo, PhD, an associate research professor at DRI who led the study. “It was important for us to reach out to community members with private wells to see how this is impacting the safety of their drinking water.” Fewer than half (41%) of the wells sampled used water treatment systems, and some treated water samples still contained arsenic levels over EPA guidelines. Although average levels of heavy metal contaminants were lower in treated water, many homes were unable to reduce contaminants to levels considered safe. The state leaves private well owners responsible for monitoring their own water quality, and well water testing helps ensure water is safe to drink. This study shows that more frequent testing is needed to ensure Nevada’s rural communities have safe drinking water. This is particularly important as the effects of climate change and population growth alter the chemistry of groundwater, potentially increasing metal concentrations. “The results emphasize the importance of regular water quality monitoring and treatment systems,” said co-author Daniel Saftner, MS, assistant research scientist at DRI. Although the research focused on wells in Nevada, other arid communities in Western states are facing similar risks of water contamination. More information: The full study, Naturally Occurring Metals in Unregulated Domestic Wells in Nevada, USA, is available from Science of The Total Environment: doi.org/10.1016/j.scitotenv.2022.158277. This project was funded by an NIH award (#1R01ES030948-01). The Healthy Nevada Project was funded by grants from Renown Health and the Renown Health Foundation. Study authors included Monica M. Arienzo (DRI), Daniel Saftner (DRI), Steven N. Bacon (DRI), Erika Robtoy (DRI), Iva Neveux (DRI), Karen Schlauch (DRI), Michele Carbone (University of Hawaii Cancer Center) and Joseph Grzymski (DRI/Renown Health). About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit dri.edu. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About the University of Hawaiʻi Cancer Center The University of Hawaiʻi Cancer Center through its various activities, including scientific research and clinical trials, adds more than $57 million to the Oʻahu economy. It is one of only 71 research institutions designated by the National Cancer Institute. An organized research unit within the University of Hawaiʻi at Mānoa, the UH Cancer Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawaiʻi and the Pacific. Learn more at https://www.uhcancercenter.org. Like us on Facebook at facebook.com/UHCancerCenter. Follow us on Twitter @UHCancerCenter.
Read More About Elevated Levels of Arsenic and Other Metals Found In Nevada Private Wells
-
Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result
Released in partnership with the Desert Research Institute: New research from the Healthy Nevada Project® finds that a confirmed diagnosis does not always result in changes to patient care. Presenting individuals with potentially life-altering health information doesn’t mean the individuals – or their healthcare providers – will act on it. Follow-up education and conversations about actionable care plans with patients and their doctors are key next steps, according to new research from the Healthy Nevada Project. The Healthy Nevada Project is a genetic screening and research project that launched in 2016 as a partnership between DRI and Renown Health. The project now has more than 50,000 participants, with genetic sequencing provided by Helix. Between September 2018 and September 2020, the Healthy Nevada Project successfully notified 293 participants that they were genetically at risk for hereditary breast and ovarian cancer syndrome, Lynch syndrome, or familial hypercholesterolemia – three common genetic conditions known collectively as the Centers for Disease Control and Prevention (CDC) Tier 1 conditions. In a study published today in Frontiers in Genetics, Healthy Nevada Project scientists looked at the impact that notifying a patient of a positive finding for a CDC Tier 1 condition had on the care that the patient received in the months and years that followed. According to their results, among the 293 Healthy Nevada Project participants who were notified of their genetic risk of a CDC Tier 1 condition, 71 percent of participants with electronic health records shared their findings with healthcare providers. However, only 30 percent of the electronic health records for these patients contained documentation of the genetic diagnosis, and only 10 percent of examined patients experienced a possible change in care after receiving the results of their genetic screening. “The Healthy Nevada Project was implemented with a ‘hands-off’ approach where the participants receive their findings and decide with whom and when to share those findings. The findings were not automatically added to their electronic health records,” said Dr. Gai Elhanan, health data scientist at DRI and co-lead author of the study. “What we’re learning now is that to ensure that important genetic findings are integrated into the care journey it is important to make their inclusion into the electronic health records part of the study.” This study builds on previous Healthy Nevada Project research published in Nature Medicine demonstrating the importance of screening for CDC Tier 1 conditions, which affect about one in 75 individuals and can be mitigated or even prevented from developing into disease when detected early. This study found that as many as 90 percent of the CDC Tier 1 cases are missed by clinical providers during normal clinical care screenings and examinations. During the current study, the Healthy Nevada Project scientists found that 19 percent of studied participants had already developed one of the CDC Tier 1 conditions, and thus would have potentially benefited from earlier notification about their condition. The study team hopes that their findings will encourage individuals in Nevada to obtain genetic testing for these relatively common conditions. Even if individuals are older or have already suffered from diseases related to these conditions, testing could also prove beneficial to siblings, children, and grandchildren who may also be at risk and who could subsequently be screened in the event of a positive finding. The study team also encourages informing health care providers of the importance of incorporating genetic diagnoses into the pharmaceutical (for example, for Familial Hypercholesterolemia) and treatment advice given to patients. “As a result of this analysis, the clinicians at Renown Health and the Healthy Nevada Project researchers have made significant changes, including obtaining informed consent from participants to report positive findings from their genetics reports directly into their electronic medical record,” said Daniel Kiser, M.S., assistant research scientist of data science at DRI and co-lead author of the study. “This will help both participants, their clinical providers, and the whole state maximize the long-term benefits of the Healthy Nevada Project voluntary population-based genetic screening.” Additional information: The full text of the study, Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record, is available from Frontiers in Genetics: https://www.frontiersin.org/articles/10.3389/fgene.2022.866169/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Genetics&id=866169. This project was funded by Renown Health, the Renown Health Foundation, and the Nevada Governor’s Office of Economic Development. Study authors included Gai Elhanan (DRI), Daniel Kiser (DRI), Iva Neveux (DRI), Shaun Dabe (Renown Health), Alexander Bolze (Helix), William Metcalf (DRI), James Lu (Helix), and Joseph Grzymski (DRI/Renown Health). For more information on the Healthy Nevada Project® or to request genetic screening, please visit: https://healthynv.org/ About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit www.dri.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision making. Learn more at www.helix.com.
-
A One Year Reflection: Thousands of Health Care Workers and Northern Nevadans Vaccinated Against COVID-19, Offering a Beacon of Hope This Holiday Season
The best protection continues to be getting a COVID-19 vaccine and booster, wearing a mask, staying at least 6 feet away from others, avoiding crowds, and washing your hands often. For the thousands of physicians and health care workers of Renown Health, this week is etched into the pandemic timeline as the start date of a nationwide wave that signaled the first vaccinations against COVID-19 and a beacon of hope for the future. A year ago, the nation’s health care systems in communities across the U.S. first began vaccinating physicians and health care workers caring for patients with COVID-19, and thousands received their first vaccine. One year ago, Renown Health, the Washoe County Health District (WCHD), the state and the Centers for Disease Control and Prevention (CDC) began to distribute the initially available, limited supplies of the COVID-19 vaccines in Washoe County. Media representatives viewed the first healthcare workers as they obtained their first dose of the life-saving vaccines. Luis Martinez, first health care worker vaccinated, now plans to attend medical school Luis Martinez, who served on the front-line of the pandemic at Renown Regional Medical Center, received the first of his Pfizer-BioNTech vaccine a year ago this week, after it received emergency use authorization from the Food and Drug Administration. He received the second and final vaccination in the series 21 days later. Luis has been at Renown since 2016, where he started as a phlebotomist and has been encouraged to advance his career in the medical field. He works as a technician on Renown’s Clinical Decision Unit — a short stay unit within the hospital for people who need clinical care, but do not need admittance to the hospital. Luis worked with patients and clinicians in the Clinical Decision Unit for a year before requesting to work in Renown’s Alternate Care Site, built in the Mill Street parking structure as a place to care for patients recovering from COVID-19 before they returned home. Today, Luis is working to fulfill his dreams of becoming a doctor. He took the Medical College Admission Test® earlier this year, interviewed virtually and applied to 24 medical schools. Luis has shadowed physicians in a number of medical fields, including internal medicine, emergency medicine, cardiology and orthopedics, and would be thrilled to train in any one of those areas. As for medical school, Luis was excited to hear about Renown’s new clinical affiliation with the University of Nevada, Reno School of Medicine (UNR Med). He is enthusiastic about becoming part of the next generation of Nevada's health care professionals, and his first choice is UNR Med. He expects an admission decision by UNR Med this winter. If that doesn’t work out, he says, he has an interview with leaders at the Kirk Kerkorian School of Medicine at UNLV in January. Luis is bilingual and understands that Nevada continues to face a shortage of physicians and affordable medical care. He volunteers with CARE Chest of Sierra Nevada, a non-profit organization that provides free medical equipment, supplies, and prescription assistance to underserved populations when he is not working at Renown. His dream is to graduate medical school and stay in the community to provide medical care as a physician. Luis knows the importance of excellent medical care, and the importance of the vaccines against COVID-19. Last October, Luis turned 33 and contracted COVID-19 after a family birthday party. Because of his experience, his interest in medicine and his research, Luis obtained his COVID-19 vaccines- and his booster, and is pleased that everyone in his family is triple vaccinated too. He says they are all feeling well and looking forward to being together at the holidays. “As we celebrate this holiday season, we give thanks for Luis and the thousands of health care heroes who have been fighting this pandemic with care and compassion; continuing to safely screen, diagnose, care for and vaccinate thousands of employees and community members,” said Tony Slonim, MD, DrPH, President & CEO of Renown Health. “It has been an honor to assist local and statewide health partners in the herculean vaccination effort. Over the past year, Renown’s vaccine team administered more than 58,000 dose 1 and dose 2 vaccinations to Nevadans ages five and older. We continue to work closely with our community health leaders and are always ready to assist. We are proud to be part of the solution for our community and pleased to have made a genuine difference in the health and well-being of others throughout this unprecedented time in our history.” Renown continues to use current local and national data, analytics, and public data sets for predictive modeling in service to our community. When there is heightened concern around an illness, enhanced infection prevention strategies are in place to ensure Renown is ready with the appropriate supplies and alternate plans should the need arise. Vaccination is still the best protection against Omicron and Coronavirus Today also marks a dark new milestone for Washoe County — over 1,010 confirmed COVID-19 deaths, and over 70,549 total cases in our population of nearly 500,000. The bright spot is that over 65,714 people have recovered in Washoe County, although many still grapple with long-term effects of the illness. The world and the U.S., continue to experience an increase in COVID-19 cases and hospitalizations with the highly contagious Omicron variant, which now accounts for 50 percent of the coronavirus cases in parts of the country. In some areas, there is a significant stress on the hospital system, particularly where vaccination rates are low. “The most important action you can take to protect yourself from the Delta and Omicron strains and the COVID-19 virus is to get fully vaccinated,” says Susan Lee, DO, MBA, Chief Medical Officer, Acute Care. “The COVID 19 virus and its related strains are preventable and controllable through safe and effective COVID-19 vaccines, which are free and now widely available in our area. The CDC recommends all people 5 years and older be vaccinated against COVID-19. Data shows that nearly all COVID-19 deaths are now occurring among unvaccinated individuals.” A list of providers in our area offering vaccines is available at vaccines.gov.” “The best protection from COVID-19 has been a combination of getting a COVID-19 vaccine, wearing a mask, staying at least 6 feet away from others, avoiding crowds, and washing your hands often,” says Amy McCombs, MSN, RN, CCRN, CNML, vice president of Quality for Acute Services for Renown, and a champion of the vaccination effort for Renown. “No one tool alone will stop this pandemic; it will take a combination of all of us using all of these efforts to fight the spread of this virus, especially through the holidays.” “Vaccinations have been a game-changer in terms of improving the health of our community,” said Rahul Mediwala, MD, Chief Medical Officer, Health Services. "Given the demands of this COVID-19 pandemic, we have been pleased to help in the fight by providing vaccinations. Our goal a year ago, was that all Renown physicians; employees and their family members; and all Hometown Health members and Renown patients interested in receiving the vaccine would have an opportunity to be vaccinated, we are excited to help make that dream a reality for all.” The COVID-19 vaccine is now mandatory for all Renown employees in an effort to protect those who are ill and physically vulnerable, and ensure a safe environment for patients and health care workers. Renown is covering all costs of the vaccine, and it is being offered free of charge to employees. As of today, 97% percent of all 6,750 Renown Health employees are vaccinated or have an approved exemption or deferral. “This year was a year no one will forget. For everyone- and for our health care workers at Renown, the year presented countless challenges and opportunities. Those of us who choose healthcare as our life’s work answer a true calling to serve others; this field requires a self-less commitment and a tireless dedication to caring for people when they are at their most vulnerable,” said Renown’s Chief of Staff, Sy Johnson, MBA. “I applaud the entire team- every physician, nurse and health care hero for their valor, their strength and perseverance in serving our patients and community during these unprecedented times.” What follows are highlights of some of the most remarkable moments and events that have taken place at Renown Health over the past year in relation to the response to COVID-19. Temporary Deployable Medical Structure Outside Renown Regional Emergency Department On March 12, 2020, Renown erected a deployable medical facility to serve as a respiratory illness evaluation and screening center for Emergency Room patients at Renown Regional Medical Center. A similar tent was also set up outside the Emergency Room at South Meadows Medical Center. An additional layer of protection, this proactive measure helped to care for people with symptoms of respiratory illness, and to protect patients and staff in the Emergency Department and other areas of the hospital. The tents were dismantled on January 20, 2021. (See photo here.) Alternate Care Site at Mill Street Parking Structure at Renown Regional As many communities across the nation experienced an increase in COVID-19 cases, including significant surges in hospitalized patients, Renown’s leadership had the foresight to create an Alternate Care Site (ACS) in the Renown Regional Medical Center Mill Street Parking structure. The ACS served additional hospitalized patients and allowed caregivers to remain on campus and still have access to existing hospital infrastructure such as lab, pharmacy, imaging, food services and other critical services. This solution also supported an efficient level of care escalation and other emergent interventions as needed. After just 10 days of intricate construction, including flooring, electrical infrastructure, lighting, water, technology and wall partitions, the ACS was completed on April 3, 2020 with space to hold up to 1,400 patients. On Nov. 12, 2020, Renown opened the ACS to serve additional hospitalized patients diagnosed with COVID-19 who were clinically stable or improving. Healthcare workers at Renown cared for hundreds of patients in this site. In early Jan. 2021, the remaining patients returned home. The Site has been decommissioned and leaders expect the area to be available for additional parking later this winter. (Alternate Care Site B-Roll.) Renown invests in Remote Patient Monitoring (RPM) ‘Hospital at Home’ Monitoring Systems Appropriate patients (including those recovering from COVID-19) are now offered a telehealth solution using wearable, continuous pulse oximetry, and the convenience of being in their own homes, with the confidence and security of knowing that Renown clinical staff are closely monitoring their health data through the Renown Transfer and Operations Center, and regularly communicating with them through their recovery process. The Renown Transfer and Operations Center spans 6,000 square feet, and is one of the largest centers of its kind in the nation, equipped with 28 high-definition dashboards on the front wall, two in the center of the room and four hanging monitors toward the back. Large plasma screens display important metrics such as patient vital signs, bed availability, facility capacity, staffing, technology and more. Registered Nurses and dispatchers continuously monitor activity around the clock, across Renown’s 100,000 square mile service area, 100+ locations and partner facilities to make the best decisions for patients, providers and care teams. “LOVE” Makes its Way to Renown On April 16, 2020, during a time of darkness and uncertainty, Artown loaned the “LOVE” sculpture, a one-ton, welded-aluminum artwork created by artist Laura Kimpton and fabricated by Jeff Schomberg to Renown, where it lit up Regional Medical Center’s main entrance on Mill St. The sculpture formerly debuted at Burning Man in 2019. On July 13, 2020, thanks to the support of former board chair and community supporter, Blake Smith and the Keyser Foundation, “LOVE” continues to glow in Renown’s signature purple every evening, shining brightly for patients, employees, visitors and passersby to enjoy. Throughout the pandemic, this sculpture has served as a source of inspiration, hope and positivity for our community. (LOVE sign B-Roll.) When Words Fail, Art Speaks Recognizing art’s powerful healing capabilities, Renown collaborated with prominent artist and fine art photographer, Anicia Beckwith, to immortalize the many battles fought against and amidst COVID-19 within the healthcare system’s walls. Beckwith captured portrait images of Renown caregivers, patients and their loved ones, showing raw and touching scenes from the COVID Intensive Care Unit, Emergency Departments, Neonatal Intensive Care Unit, Wilbur D. May Pediatric Intensive Care Unit and the Alternate Care Site field hospital. A group of Renown caregivers hold a COVID patient’s hand. Tears well up in their eyes as the patient takes his last breath. Care providers respond to a patient’s only request – a facial shave. The man beams at the sight of his freshly groomed face, and is visibly touched by the tender care he received to make it happen. Lupe, an environmental services worker, takes special care in her efforts to clean and sanitize patient rooms—a craft she has perfected and taken pride in for the 25+ years she’s worked at Renown. These are just a few of the captivating moments Beckwith illustrates through her art. Beckwith’s full photo gallery of images from Renown are located here; and downloadable visual assets are available here. Evolving in an Ever-Changing World: Long-Term Remote Work for Renown Employees The COVID-19 pandemic pushed healthcare leaders throughout the world to determine how best to provide care in this ever-changing environment. Leaders in Renown’s Human Resources department evaluated the thoughts and opinions of employees working remotely throughout Renown Health. Due to the positive feedback from employees, including decreased commute times, fewer distractions, improved work-life balance and a reduced carbon footprint, over 700 Renown employees will continue working remotely. Renown Offers In-House COVID Testing In June 2020, the Renown Laboratory team sprang into action to help meet Washoe County residents and businesses’ growing demand for COVID-19 testing. Renown invested in expanded staffing and in-house testing capabilities to be able to swab and process up to 1,000 COVID tests for patients each day, with return of results within hours. Renown’s CEO, Dr. Tony Slonim also collaborated with the Mayor’s COVID-19 Task Force, local faith and community leaders beginning in Oct. of 2020 to address health equity by providing free COVID-19 testing for communities of color. (Lab B-Roll). An Extraordinary Year of Service Renown’s leadership remains steadfast commitment to keeping our community safe. “We thank the community for standing by us and helping us all emerge as stronger people with hope for the future. We continue to fight the good fight,” said Dr. Slonim. “With COVID now imbedded into our daily lives, it’s remarkable to reflect on the progress we’ve made and the obstacles we’ve overcome. I will be forever grateful for the precautionary measures, innovation, and acts of service and love implemented by our dedicated team over the past two years. We hope by demonstrating our caring values and exhibiting hope and determination, we are inspiring others.” Stay Up-to-date on COVID-19 Renown Health is prepared to safely screen, diagnose and care for patients with respiratory illness, including COVID-19. To stay up-to-date on communications regarding Renown’s distribution of the COVID19 vaccine, FAQs and the scientific evidence behind the vaccine, visit https://covid.renown.org/ Join the Renown team Renown Health remains committed to hiring key roles in our organization to support the health and well-being of our community. To join the Renown family to Fight the Good Fight, apply on line at https://careers.renown.org/ Support the Renown team Renown Health, a charitable, not-for-profit organization, is grateful for our community’s support during these unprecedented times. If you are interested in supporting Renown Health, a charitable, non-profit health organization, please consider giving to Renown Health Foundation. Donations are accepted through the following ways: Make a gift at www.renown.org/give Call Renown Health Foundation at 775-982-5545 Mail a check to Renown Health Foundation, 1155 Mill St., O2, Reno, NV 89502 Venmo: @RenownFoundation About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.
-
Fighting for Your Health and Safety; As COVID-19 Cases Rise, Renown is Prepared
Protect yourself by obtaining a vaccination against COVID-19 and the Delta strain if you are 12 years or older; seek urgent care if needed The world, the country and our area continue to experience an increase in COVID-19 cases and hospitalizations with the highly contagious Delta SARS-CoV-2 virus strain. The Renown Health team continues to safely screen, diagnose and care for patients with respiratory illnesses, including those at risk for COVID-19. Renown continues to use current local and national data, analytics, and public data sets for predictive modeling in service to our community. Renown Health ensures constant readiness by working closely with the Washoe County Health District, the Governor’s office, and is informed by updates from the Centers for Disease Control and Prevention (CDC). When there is heightened concern around an illness, we implement enhanced infection prevention strategies to ensure we are ready with the appropriate supplies and alternate plans should the need arise. Renown Health providers are educated and prepared to quickly and safely screen, diagnose and care for patients with respiratory illness, including COVID-19. Vaccination is the best protection against Delta. “The most important action you can take to protect yourself from the Delta strain and the COVID-19 virus is to get fully vaccinated,” says Brion Hill, MD who practices at the Renown Urgent Care - Los Altos location. “The COVID 19 virus and Delta strain is preventable and controllable through safe and effective COVID-19 vaccines, which are free and now widely available in our area. The CDC recommends all people 12 years and older be vaccinated against COVID-19. Recent data show that nearly all COVID-19 deaths are now occurring among unvaccinated individuals.” A list of providers in our area offering vaccines is available at vaccines.gov.” Protecting Yourself, Friends and Family Dr. Hill adds, “You can protect yourself the same way you would protect against other viruses with a few common-sense practices.” Wear a cloth mask or medical procedure mask when in a public setting. For situations when you are in close contact with people who do not live with you, you may want to consider a mask option that provides a higher level of protection (improved fit and/or improved filtration). Wash your hands thoroughly and often. Make sure you are cleaning between your fingers and under your nails. Use alcohol-based sanitizers when soap and water are not available. Use disposable tissues when coughing and sneezing; dispose of carefully and promptly. If tissues are not available, direct your cough or sneeze into the crook of your arm/sleeve. Avoid touching your eyes, nose, and mouth with unwashed hands. Clean and disinfect frequently touched objects and surfaces. Avoid close contact with anyone who has cold or flu-like symptoms. Avoid shaking hands, especially with those who appear to be ill. Disinfect shared surfaces. Practice social distancing, 6 feet or more. Stay home when you are sick. If you have fever, cough, gastrointestinal, or respiratory symptoms please call your medical provider and explain your symptoms before coming in to their offices. If you do not have a health care provider, and have medical concerns that are urgent but not life-threatening, visit a Renown Urgent Care physician or healthcare provider. Virtual Urgent Care is available for people for COVID-19 symptoms and Virtual Urgent Care visits are available through MyChart. MyChart is a free, secure online patient portal that allows you to access your Renown Health medical record and manage your health care information. There are 11 conveniently located Renown Urgent Care offices with providers ready to see you 7 days a week. You have the option to book ahead and schedule an appointment at 11 locations near you. How to Get Accurate and Reliable Information: We continue to advise our community regarding the importance of accurate sources of information, and to provide regular updates. For up-to-date information on Renown’s approach to keeping our community safe, visit our website at renown.org. About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, the region’s only children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improving the care and the health of our community. For more information, visit renown.org.
Read More About Fighting for Your Health and Safety; As COVID-19 Cases Rise, Renown is Prepared
-
Renown Thanks Community as COVID-19 Drive-Thru Ends
After administering more than 73,000 dose one and dose two vaccinations to our community, Renown's vaccine team will conclude its efforts at Renown's drive-thru site later this month. Renown Health has been pleased to work with the Washoe County Health District, the state, and the CDC to distribute the limited supplies of COVID-19 vaccines. Leaders of the COVID-19 vaccine taskforce at Renown announced today that Wednesday, May 12, 2021 will be the last day the organization will administer dose one of the COVID-19 vaccine to community members at Renown’s drive-thru clinic. Renown's vaccine clinic will remain open until all individuals who receive their first dose of the vaccine through Renown have the opportunity to receive their second dose. To date, Renown’s vaccine team has administered more than 73,000 dose 1 and dose 2 vaccinations to medical staff members, Renown employees, students, volunteers and eligible community members. “It has been an honor assisting our local and statewide health partners in the herculean feat of vaccinating the hundreds of thousands of area residents excited to receive the vaccine,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “As we conclude our efforts at our drive-thru vaccine clinic, we are glad to continue working closely with our community health leaders and be ready to assist once again should there be a need for our support in the future. We are proud to be part of the solution for our community and pleased to have made a genuine difference in the health and well-being of others throughout this unprecedented time in our history.” “As we look forward to a brighter future beyond the pandemic, we can’t help but reflect on the more than 73,000 vaccine doses our teams administered to our community,” said Melodie Osborn, RN, Chief Nursing and Quality Officer for Health Services at Renown. “From our nurses, pharmacists, security teams, public safety experts and countless volunteer staff, each dose of the vaccine was made possible—rain, snow or shine—by dedicated healthcare champions committed to the health and safety of northern Nevadans.” “We want to offer our sincere gratitude and appreciation to the public for placing their trust in Renown to receive their vaccines, and for their patience and support of this important work,” said Wendy Meyers, Manager of Health and Wellness at Hometown Health. “The masked smiles, emotional tears of gratitude and relief, heartfelt thanks, food deliveries and many other acts of kindness will forever hold a special place in our hearts.” Community members 16+ still interested in receiving the Pfizer vaccine at Renown on May 12 are invited to make an appointment through MyChart; and walk-ins will be accepted from noon to 2 p.m. Minors ages 16 and 17 must be with a parent or guardian to receive the vaccine. For assistance, please call 775-982-2781. To schedule your COVID-19 appointment in Washoe County outside of Renown, please visit covid19washoe.com. Renown will continue providing ongoing updates to help keep our community safe on our website at covid.renown.org. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include; Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org
Read More About Renown Thanks Community as COVID-19 Drive-Thru Ends
-
Businesses: Get Employees Vaccinated Against COVID-19 for Free
Renown Health has been working with the Washoe County Health District, the state, and the CDC to distribute the limited supplies of COVID-19 vaccines. Renown has completed more than 64,000 dose 1 and dose 2 vaccinations to date, which includes all of Tier 1A (Medical Staff members, Renown employees, students and volunteers) and eligible community members – which now includes everyone 16+. “Renown is excited to continue along our goal of providing the opportunity for everyone who is interested in receiving the vaccine to be vaccinated at no charge,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “We would like local businesses to know we have thousands of open appointments in early May and we encourage our business colleagues to share this information with employees so they may easily schedule an appointment through MyChart and continue on the path to a healthier and safer northern Nevada.” “Renown is excited to continue along our goal of providing the opportunity for everyone who is interested in receiving the vaccine to be vaccinated at no charge,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “We would like local businesses to know we have thousands of open appointments in early May and we encourage our business colleagues to share this information with employees so they may easily schedule an appointment through MyChart and continue on the path to a healthier and safer northern Nevada.” Vaccine appointments for 18+ Anyone ages 18 and older may register for a free Renown Epic MyChart account. They do not need to have a Renown provider to enroll. With a MyChart account, they will be able to login and schedule their first vaccine appointment. These vaccines require two doses. After the first dose of the vaccine is documented in your MyChart account, you will get a notice to schedule your second dose. There are two easy ways to sign up for MyChart. Please see instructions in both English and Spanish. To schedule an appointment for a 16 or 17 year old: We have made special arrangements for minors ages 16 and 17. Please fill out this form, also found on https://covid.renown.org/vaccine/. Renown's Customer Engagement team will call the listed phone number within 14 business days to schedule the appointment. We appreciate your patience during this time as demand is high. Please note that a parent or guardian must accompany the teen when getting their vaccination. You are advised NOT to receive the vaccine if you: Are ill at the time of vaccination (fever, shortness of breath, vomiting, diarrhea or acute illness). Have been diagnosed with COVID-19 in the previous 14 days. Have received any other vaccination in the last 14 days. Have a history of significant allergic reaction to this vaccine or any of its ingredients. “Hometown Health is proud to be part of an organization offering COVID-19 vaccines to our community at no cost,” said David Hansen, CEO, Hometown Health. “The business community in northern Nevada is an important piece of the vaccination puzzle, and as a community-focused organization, we are pleased that Renown can safely offer vaccinations to local businesses and contribute to an increased hope for the future.” Renown will provide additional updates on our websites at covid.renown.org. Please see b-roll, photos and fly-over footage of our Drive-Thru COVID-19 Vaccination Clinic here. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include; Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org
Read More About Businesses: Get Employees Vaccinated Against COVID-19 for Free
-
Leading U.S. Hospitals Team Up To Promote COVID-19 Vaccine
A coalition of 60 top hospitals and healthcare institutions have joined forces in a nationwide campaign to encourage adults to get vaccinated against COVID-19. Led by Cleveland Clinic and Mayo Clinic, the campaign "Get the Vaccine to Save Lives" is designed to reassure the public that vaccines are safe, effective and necessary to achieve herd immunity and return to normal activities. "We're asking people to talk to their healthcare providers if they have questions and then get vaccinated," says Gianrico Farrugia, M.D., Mayo Clinic's president and CEO. "The vaccine is our strongest asset to end the pandemic, and I urge everyone who is eligible to get whichever vaccine you're first offered to save lives." The campaign hopes to reach adults who are hesitant to receive a vaccine, including racial and minority ethnic groups and people living in rural communities. According to a Kaiser Family Foundation survey published March 30, 17% of the public say they will take a wait-and-see approach before getting it themselves, and another 20% say they will never get a vaccine or will only get it if required to do so for work, school or other activities. This leaves a significant portion of the population at risk of going unvaccinated. The nationwide campaign includes print and digital advertising, media outreach, social media, an awareness video and an informational website. "The COVID-19 vaccine is safe and highly effective and offers our best hope for beating the disease," said Tom Mihaljevic, M.D., Cleveland Clinic's CEO and president. "We all want to see a return to our pre-COVID routines, when we can once again gather safely with family and friends. To reach that goal, we must improve vaccination rates to achieve herd immunity. Please sign up today because we are all in this together." With vaccine distribution underway, the campaign aims to help Americans feel safe and confident about receiving a vaccine. To achieve herd immunity and help end the pandemic, leading health officials say at least 75% of the population needs to receive a vaccine. Herd immunity occurs when a large portion of a community becomes immune to a disease, making the spread of disease from person to person unlikely. As a result, the whole community becomes protected — not just those who have been vaccinated. In addition to Mayo Clinic and Cleveland Clinic, 58 other leading U.S. healthcare institutions have joined the campaign. They include: Advent Health Adventist Health Allegheny Health Network Ann & Robert H. Lurie Children's Hospital of Chicago Arizona Medical Association Ascension St. Vincent's Atrium Health Banner Health Baptist Health South Florida Baylor Scott & White Health Beaumont Health BJC HealthCare Brooks Rehabilitation Broward Health Centura Health Einstein Healthcare Network Emory Healthcare Essentia Health Hackensack Meridian Honor Health Intermountain Healthcare Lee Health Mass General Brigham McLaren St. Luke's MedStar Health Memorial Healthcare System Memorial Sloan Kettering Cancer Center Mercy Health Michigan Medicine Monument Health NCH Healthcare System Nicklaus Children's Health System North Shore University Health System Northwestern Medicine Norton Healthcare Peace Health Piedmont Healthcare ProMedica Renown Health Rush University Medical Center Chicago Southwestern Health Resources Spectrum Health Summit Health Texas Health The Ohio State University Wexner Medical Center and The James Cancer Hospital The Toledo Clinic The University of Texas MD Anderson Cancer Center Theda Care UC Health (Cincinnati) UNC Health University Hospitals University of Chicago Medicine University of Iowa Health Care University of Toledo Medical Center UT Southwestern Medical Center Virtua Health Well Span Health Yale New Haven Health More than 209 million doses of COVID-19 vaccine have been administered and 50% of the population age 18 and over has received at least one vaccine dose in the U.S. through April 18, according to the Centers for Disease Control and Prevention. COVID-19 vaccines were evaluated in tens of thousands of participants in clinical trials. The vaccines met the Food and Drug Administration's rigorous scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization. Ethos Creative Group of Burlington, North Carolina, created the campaign and donated their services. Facebook, iHeartRadio, Spectrum Reach, The New York Times, The Washington Post, USA Today, and YouTube also provided complimentary resources. For more information about the campaign, visit ourshot2savelives.org About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.
Read More About Leading U.S. Hospitals Team Up To Promote COVID-19 Vaccine
-
Researchers at Renown Seek Convalescent Plasma Study Participants
Physician researchers seek to understand how the immune system responds to COVID-19 and create a healthier Nevada. During the early stages of the pandemic, convalescent plasma was considered the only viable treatment option available for patients with COVID-19. Convalescent plasma is the component of the blood from recovered patients that may contain COVID-19 antibodies that help fight the infection. The National Institutes of Health has since developed treatment guidelines for COVID-19 based on clinical trial data and many studies are still underway worldwide assessing various additional treatment options. Convalescent plasma was in high demand but difficult to locate for COVID-19 patients in the northern Nevada area. A 24-year-old nursing assistant, Austin Meegan, was hospitalized and spent weeks staving off kidney and lung failure before learning he was eligible for an experimental blood transfusion that showed promise in treating COVID-19. Doctors estimated Meegan had only about a 3% chance of tracking down a donor to match his rare blood type. A COVID-19 survivor, Thomas Gibson, a Texas resident with the same blood type, traveled to Reno to donate his viral antibodies and a convalescent plasma donation credited with helping to save Meegan’s life. Physician clinical researchers and scientists at Renown and the University of Nevada, Reno School of Medicine (UNR Med) knew they needed to create better options for patients and physicians. Clinical researchers developed a study to help other patients like Austin, and pleaded for donations from recovered COVID-19 patients to donate their convalescent plasma. The researcher teams looked to understand how the body’s immune system responds to the virus over time, to aid them in developing new treatments for COVID-19. “The world’s capacity to get through the COVID crisis will depend on four things — science, technology, innovation and partnerships, says Tony Slonim, MD, DrPH, President and CEO of Renown Health. “Taking lab bench discoveries to the bedside of patients in an efficacious and timely manner is not easy, but with UNR Med and our partners, we are making great strides in advancing clinical research which has the power to save lives and to create a healthier Nevada.” “It’s tremendously promising to partner on clinical research that will not only help us better understand the disease, but help inform treatment for those combatting COVID-19 that has had such a devastating impact on Nevadans, our nation and the world,” says UNR Med Dean Thomas L. Schwenk, MD. Renown, UNR Med and other area health care partners collaborated with Vitalant to collect plasma from recovered donors for a study on the treatment's efficacy. Eligible donors are at least 18 years old, weigh more than 110 pounds and are healthy. Donors had fully recovered from a confirmed diagnosis of COVID-19. Project coordinators at the Renown Research Office were overwhelmed by the community’s support and plasma blood donations. Additional partnerships with the Washoe County Health District, the State of Nevada and the Governor’s office, Saint Mary’s Medical Center, Northern Nevada Medical Center, Carson Tahoe Health and the VA Sierra Nevada Health Care System, along with many area health care providers helped the team meet their goals of enrolling 120 eligible participants in the study. “Our success in this study rests heavily on the support of our great community, as well as the innovation and collaboration demonstrated by Renown and UNR Med,” said Sara Healy, MD, MPH, principal investigator of the study and a pediatric infectious disease physician at Renown Children’s Hospital and UNR Med. “We are proud to be at the forefront of conducting essential research during such a pivotal time in history, and look forward to our continued partnership as we continue this important work.” “The control of COVID-19 in our communities relies on testing. The study that is being launched to develop a sensitive, specific and easier way to collect specimens (blood) is advancing the field and brings promise towards getting to our common goal of having the right diagnostic test for the right clinical situation at the right time,” says Mark Riddle, MD, DrPH, FISTM, associate investigator of the study and associate dean for clinical research and professor at UNR Med's Department of Internal Medicine and Medical Research. The research team is now asking area residents to participate in a study to analyze the efficacy of two COVID-19 tests. Participants will undergo two blood tests: one being a finger stick to provide results for a rapid test, and the other is a traditional venipuncture draw confirming the presence or absence of COVID-19 antibodies. This study is a collaboration with InBios International, Inc., a leading biotechnology company based in Seattle. Researchers are seeking: Individuals who have confirmed positive for COVID-19 and who have recently recovered from the virus. Study participants must be within 7-28 days from the onset of their symptoms. Individuals who have recently tested negative for COVID-19 and have never tested positive. Those who are interested in participating in the study may contact project coordinators at the Renown Research Office at (775) 982-3646, or via e-mail at covidplasmascreening@renown.org, 7:30 A.M. – 5:00 P.M., Monday through Friday. Individuals aged 18-75 in general good health are encouraged to consider participating in this ongoing study. There is no cost to participate in this study and participation is voluntary. An individual’s decision to participate will not affect their current or future relations with their health care provider(s), health district, or the community. Those who decide to participate are free to withdraw at any time. “Time is of the essence with COVID. If we can get test results to people and their clinicians in a more timely way, we can make a faster diagnosis of a patient's condition, says Christopher M. Kozlowski, MD, MHA, Renown's institutional research officer and Medical Director/VP of Renown Institute for Heart & Vascular Health. “As we refine the accuracy of our testing; we are applying sensitivity and specificity testing for true negative and true positive results. This provides people with more timely and accurate results and better quality care.” About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improve the care and the health of our community. About the University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Established in 1969, UNR Med is improving the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.
Read More About Researchers at Renown Seek Convalescent Plasma Study Participants